IRIDEX Corporation Stock News

New York, March 03, 2020 -- Reportlinker.com announces the release of the report "Global Ophthalmic Diagnostic Devices Market 2020-2024" -.

MOUNTAIN VIEW, Calif., Feb. 28, 2020 -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth quarter and full year of.

IRIDEX Corporation (IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today the introduction of the second generatio

Gainers Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) shares gained 78.5% to close at $3.66 after the company announced a license agreement with Zhejiang HaiChang Biotechnology....

Anyone researching IRIDEX Corporation (NASDAQ:IRIX) might want to consider the historical volatility of the share...

Toward the end of trading Tuesday, the Dow traded down 0.05% to 28,893.91 while the NASDAQ fell 0.34% to 9,242.31. The S&P also fell, dropping 0.28% to 3,278.76. Leading and...

Midway through trading Tuesday, the Dow traded up 0.38% to 29,018.33 while the NASDAQ rose 0.01% to 9,274.37. The S&P also rose, gaining 0.01% to 3,288.18. Leading and Lagging...

IRIDEX Corporation (IRIX) today provided preliminary operational and financial results for the fourth quarter and full year ended December 28, 2019. Total revenue for the fourth quarter of 2019 expec